Navigation Links
Sunpeaks Ventures Announces Agreement with Asian American Convenience Store Association Partners to Sell Clotamin in 1,200 Stores
Date:4/4/2012

SILVER SPRING, Md., April 4, 2012 /PRNewswire/ -- Sunpeaks Ventures, Inc. (OTCBB: SNPK) (PINKSHEETS: SNPK) (the "Company" or "Sunpeaks Ventures") and its wholly owned subsidiary Healthcare Distribution Specialists, LLC ("HDS") are pleased to announce that HDS has signed a marketing and distribution agreement with Asian American Convenience Store Association Partners and Skyrock ("AACSA Partners/Skyrock") to distribute and sell Clotamin in 1,200 AACSA member locations, including convenience stores, pharmacies, and small grocers.  If successful, the parties anticipate expanding the initial program nationwide up to 10,000 additional locations.  This Agreement will continue in effect for three (3) years.  

"This is a milestone agreement for the Company and a huge leap forward for widespread Clotamin availability.  Our agreement with AACSA/Skyrock can quickly place Clotamin in potentially thousands of hard-to-reach locations across the country," stated Mackie A. Barch, CEO of Sunpeaks Ventures.  "In addition to the distribution, AACSA will market Clotamin to its members and its sister group of Asian American and Indian physicians.  Reaching this highly fragmented, yet extremely influential group is near impossible without the help of a strong industry partner.  By leveraging AACSA/Skyrock's established relationships with its member stores, we should be able to rapidly penetrate this market on a large scale."

The Asian American Convenience Stores Association ("AACSA") is an industry trade association representing thousands of stores nationwide.  AACSA has been an advocate for the convenience retailing industry providing industry information, knowledge and connections to ensure the competitive viability of member businesses.  AACSA has approximately 50,000 affiliate members. The convenience retail sector has undergone significant growth over the past three decades; ten years ago, the official industry store count stood at 100,800; 20 years ago there were 76,200 stores; and 30 years ago there were only 24,300.  Today, the U.S. convenience store industry is comprised of nearly 145,000 stores which posted $511 billion in total sales in 2009. 

About Sunpeaks Ventures, Inc.

Sunpeaks Ventures, Inc. and its wholly owned subsidiary Healthcare Distribution Specialists, LLC ("HDS"), is a nationally focused, value-added distributor of specialty drugs and over-the-counter ("OTC") branded multivitamins to the healthcare provider market.   HDS also owns and markets Clotamin®, a specialized over-the-counter multivitamin product designed exclusively for use by patients also on Warfarin®, a popular blood thinner that has a long list of known adverse drug and food interactions.

For additional information, please visit www.sunpeaksventures.com.

Contact: Financial Insights 888-248-8491 or info@sunpeaksventures.com

Safe Harbor Statement

Information in this document constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  The words "forecast", "anticipate", "estimate", "project", "intend", "expect", "should", "believe", and similar expressions are intended to identify forward-looking statements.  These forward-looking statements involve, and are subject to known and unknown risks, uncertainties and other factors which could cause Sunpeaks Ventures' actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements.  The risks, uncertainties and other factors are more fully discussed in Sunpeaks Ventures' filings with the U.S. Securities and Exchange Commission.  All forward-looking statements attributable to Sunpeaks Ventures herein are expressly qualified in their entirety by the above-mentioned cautionary statement.  Sunpeaks Ventures disclaims any obligation to update forward-looking statements contained in this estimate, except as may be required by law.


'/>"/>
SOURCE Sunpeaks Ventures, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Sunpeaks Ventures Announces Agreement with Albeck Financial Services
2. Sunpeaks Ventures Announces Clotamin to Be Sold at Winn-Dixie Locations in South Florida
3. Sunpeaks Ventures Announces Clotamin to be Sold at Bravo Supermarkets in South Florida
4. Sunpeaks Ventures to Participate in ECRM Conference and Expo
5. Sunpeaks Ventures Announces Clotamin to be Sold at Navarro Discount Pharmacies
6. Sunpeaks Ventures Announces Clotamin available on Walgreens.com
7. Sunpeaks Ventures Enters $45 Billion Specialty Drug Distribution Sector
8. Sunpeaks Ventures Completes Acquisition of Healthcare Distribution Specialists LLC
9. GMH Ventures Acquires Majority Ownership in Dynamic Healthcare Services, Leading Provider of Medical Equipment and Respiratory Therapy Products and Services
10. Vivo Ventures Closes $375 Million 7th Fund to Invest in Healthcare in the U.S. and Greater China
11. Global Diagnostic Imaging Companies M&A, Joint Ventures, R&D Pipeline, and Strategies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... , Feb. 4, 2016 Worldwide Radiology ... significant growth as next generation systems provide a ... radiology for cancer surgery. New systems pinpoint the ... that has been such a problem previously, limiting ... Radiosurgery robots take cancer surgery far beyond what ...
(Date:2/4/2016)... LONDON , Feb. 4, 2016 ... Summary Global Markets Direct,s, ,Wegener Polyangiitis - ... the Wegener Polyangiitis,s therapeutic pipeline. This report ... Wegener Polyangiitis, complete with comparative analysis at various ... action (MoA), route of administration (RoA) and molecule ...
(Date:2/4/2016)... , Feb. 4, 2016 Global ... competitive market to drive long-term market growth ... common set of chronic disorders that affect 5–7% ... in terms of their symptoms and key patient ... dysregulation of immune pathways and an inappropriate immune ...
Breaking Medicine Technology:
(Date:2/6/2016)... ... 2016 , ... Research has shown that building shame resilience ... and level of relapse. , At the 2016 iaedp Symposium, the ... the critical tasks of the recovery phase and beyond including relapse prevention and ...
(Date:2/5/2016)... , ... February 05, 2016 , ... ... availability of the company's lighter, sleeker next generation LYNX VR Indoor Trainer with ... , Improvements in design and manufacturing not only reduce the weight of the ...
(Date:2/5/2016)... ... , ... The event is being held on April 7, 2016 from 5:30 ... Over Parkinson’s will fund nearly $100,000 for research for the care and cure of ... and is the architect of this informative event to raise awareness and funds for ...
(Date:2/5/2016)... ... February 05, 2016 , ... Looking for a last-minute Valentine’s Day ... tips of your toes. Foot massage, whether administered by a professional masseuse or a ... The American Board of Multiple Specialties in Podiatry (ABMSP) has taken the ...
(Date:2/5/2016)... Florida (PRWEB) , ... February 05, 2016 , ... ... non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma ... – is poised to once again host, Swirl, A Wine Tasting Event at ...
Breaking Medicine News(10 mins):